Short communicationPublished 20 May 2021

Insight into the pathogenesis of Autologous Platelet Plasma (APP

Authors: Amalia Kerl-Skurka

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Evaluation of effectiveness of treatment for Autologous Platelet Plasma (APP) with and without patients with osteoarthrosis; parameters are “Pain”, “Stiffness”, “Functional limitation", normalized WOMAC index scores, timed 20 meter walk test before and after degenerative arthritis disease (gonathritis and coxarthritis) and the intervertebral spinal cord symptomatology are one of the major health problem for the patients in the working age (30-60 years). Every third working person (between 30-60 years) suffers from joint diseases. The Autologous Platelet Plasma (APP) with or without ozone therapy can reduce the time of convalescence, allowing patients quick recovery and restart their work. The comfort is also better post therapeutic in this form of therapies

Subjects

Orthopaedics

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.

Try:

More from this journal

The newest in Journal of Clinical & Experimental Orthopaedics.

All its articles

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical & Experimental Orthopaedics
  • SubjectOrthopaedics
  • BylineArticles whose byline prints “Amalia Kerl-Skurka”